Ventus Therapeutics, Inc., A Biopharmaceutical Company, Announced That The Company Has Entered Into An Exclusive Worldwide License Agreement With Novo Nordisk A/S To Develop And Commercialize Candidates From Ventus
Found this useful? Share it with your team.
